-
Something wrong with this record ?
Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells
M. Karasová, J. Procházková, Z. Tylichová, R. Fedr, M. Ciganek, M. Machala, Z. Dvořák, B. Vyhlídalová, I. Zůvalová, J. Ehrmann, J. Bouchal, Z. Andrysík, J. Vondráček
Language English Country Switzerland
Document type Journal Article
Grant support
19-00236S
Czech Science Foundation
NU21-03-00421
Ministry of Health
BBMRI-CZ No. CZ.02.1.01/0.0/0.0/16_013/0001674
European Regional Development Fund
RVO: 68081707
Czech Academy of Sciences
RO0520
Ministry of Agriculture
DRO-FNOL00098892
Ministry of Health
NLK
Free Medical Journals
from 2009
PubMed Central
from 2009
Europe PubMed Central
from 2009
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Open Access Digital Library
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2009
- Publication type
- Journal Article MeSH
The aryl hydrocarbon receptor (AhR) plays a wide range of physiological roles in cellular processes such as proliferation, migration or control of immune responses. Several studies have also indicated that AhR might contribute to the regulation of energy balance or cellular metabolism. We observed that the AhR is upregulated in tumor epithelial cells derived from colon cancer patients. Using wild-type and the corresponding AhR knockout (AhR KO) variants of human colon cancer cell lines HCT116 and HT-29, we analyzed possible role(s) of the AhR in cell proliferation and metabolism, with a focus on regulation of the synthesis of fatty acids (FAs). We observed a decreased proliferation rate in the AhR KO cells, which was accompanied with altered cell cycle progression, as well as a decreased ATP production. We also found reduced mRNA levels of key enzymes of the FA biosynthetic pathway in AhR KO colon cancer cells, in particular of stearoyl-CoA desaturase 1 (SCD1). The loss of AhR was also associated with reduced expression and/or activity of components of the PI3K/Akt pathway, which controls lipid metabolism, and other lipogenic transcriptional regulators, such as sterol regulatory element binding transcription factor 1 (SREBP1). Together, our data indicate that disruption of AhR activity in colon tumor cells may, likely in a cell-specific manner, limit their proliferation, which could be linked with a suppressive effect on their endogenous FA metabolism. More attention should be paid to potential mechanistic links between overexpressed AhR and colon tumor cell metabolism.
Department of Experimental Biology Faculty of Science Masaryk University 62500 Brno Czech Republic
Department of Pharmacology and Toxicology Veterinary Research Institute 62100 Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno 65691 Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22023400
- 003
- CZ-PrNML
- 005
- 20221031095220.0
- 007
- ta
- 008
- 221010s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cancers14174245 $2 doi
- 035 __
- $a (PubMed)36077780
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Karasová, Martina $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, 62500 Brno, Czech Republic
- 245 10
- $a Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells / $c M. Karasová, J. Procházková, Z. Tylichová, R. Fedr, M. Ciganek, M. Machala, Z. Dvořák, B. Vyhlídalová, I. Zůvalová, J. Ehrmann, J. Bouchal, Z. Andrysík, J. Vondráček
- 520 9_
- $a The aryl hydrocarbon receptor (AhR) plays a wide range of physiological roles in cellular processes such as proliferation, migration or control of immune responses. Several studies have also indicated that AhR might contribute to the regulation of energy balance or cellular metabolism. We observed that the AhR is upregulated in tumor epithelial cells derived from colon cancer patients. Using wild-type and the corresponding AhR knockout (AhR KO) variants of human colon cancer cell lines HCT116 and HT-29, we analyzed possible role(s) of the AhR in cell proliferation and metabolism, with a focus on regulation of the synthesis of fatty acids (FAs). We observed a decreased proliferation rate in the AhR KO cells, which was accompanied with altered cell cycle progression, as well as a decreased ATP production. We also found reduced mRNA levels of key enzymes of the FA biosynthetic pathway in AhR KO colon cancer cells, in particular of stearoyl-CoA desaturase 1 (SCD1). The loss of AhR was also associated with reduced expression and/or activity of components of the PI3K/Akt pathway, which controls lipid metabolism, and other lipogenic transcriptional regulators, such as sterol regulatory element binding transcription factor 1 (SREBP1). Together, our data indicate that disruption of AhR activity in colon tumor cells may, likely in a cell-specific manner, limit their proliferation, which could be linked with a suppressive effect on their endogenous FA metabolism. More attention should be paid to potential mechanistic links between overexpressed AhR and colon tumor cell metabolism.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Procházková, Jiřina $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic $1 0000000327388546
- 700 1_
- $a Tylichová, Zuzana $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic $1 0000000304335505
- 700 1_
- $a Fedr, Radek $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, 65691 Brno, Czech Republic
- 700 1_
- $a Ciganek, Miroslav $u Department of Pharmacology and Toxicology, Veterinary Research Institute, 62100 Brno, Czech Republic
- 700 1_
- $a Machala, Miroslav $u Department of Pharmacology and Toxicology, Veterinary Research Institute, 62100 Brno, Czech Republic
- 700 1_
- $a Dvořák, Zdeněk $u Department of Cell Biology and Genetics, Faculty of Science, Palacký University, 78371 Olomouc, Czech Republic $1 0000000239383585
- 700 1_
- $a Vyhlídalová, Barbora $u Department of Cell Biology and Genetics, Faculty of Science, Palacký University, 78371 Olomouc, Czech Republic
- 700 1_
- $a Zůvalová, Iveta $u Department of Cell Biology and Genetics, Faculty of Science, Palacký University, 78371 Olomouc, Czech Republic
- 700 1_
- $a Ehrmann, Jiří $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University and University Hospital, 77900 Olomouc, Czech Republic
- 700 1_
- $a Bouchal, Jan $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University and University Hospital, 77900 Olomouc, Czech Republic $1 0000000348421720
- 700 1_
- $a Andrysík, Zdeněk $u Linda Crnic Institute for Down Syndrome, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA $u Department of Pharmacology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
- 700 1_
- $a Vondráček, Jan $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 61265 Brno, Czech Republic $1 0000000340711969
- 773 0_
- $w MED00173178 $t Cancers $x 2072-6694 $g Roč. 14, č. 17 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36077780 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20221010 $b ABA008
- 991 __
- $a 20221031095218 $b ABA008
- 999 __
- $a ind $b bmc $g 1853849 $s 1174688
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 14 $c 17 $e 20220831 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
- GRA __
- $a 19-00236S $p Czech Science Foundation
- GRA __
- $a NU21-03-00421 $p Ministry of Health
- GRA __
- $a BBMRI-CZ No. CZ.02.1.01/0.0/0.0/16_013/0001674 $p European Regional Development Fund
- GRA __
- $a RVO: 68081707 $p Czech Academy of Sciences
- GRA __
- $a RO0520 $p Ministry of Agriculture
- GRA __
- $a DRO-FNOL00098892 $p Ministry of Health
- LZP __
- $a Pubmed-20221010